JIANGSU YANGNONG CHEMICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.61 CNY | +1.16% |
|
+6.44% | +2.36% |
| Apr. 22 | Jiangsu Yangnong Chemical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 26 | Yangnong Chemical's 2023 Profit Slips 13% as Revenue Drops 27% | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 21,268 | 40,907 | 40,659 | 32,198 | 25,650 | 26,256 | - | - |
| Enterprise Value (EV) 1 | 21,268 | 40,020 | 39,474 | 29,652 | 24,508 | 24,891 | 23,292 | 21,920 |
| P/E ratio | 18.2 x | 33.8 x | 33.3 x | 17.9 x | 16.3 x | 17.3 x | 13.2 x | 11.7 x |
| Yield | 0.95% | 0.49% | 0.5% | 1.25% | 1.39% | 1.38% | 2.12% | 1.98% |
| Capitalization / Revenue | 2.44 x | 4.16 x | 3.43 x | 2.04 x | 2.23 x | 1.91 x | 1.6 x | 1.53 x |
| EV / Revenue | 2.44 x | 4.07 x | 3.33 x | 1.88 x | 2.14 x | 1.81 x | 1.41 x | 1.28 x |
| EV / EBITDA | 12 x | 21.9 x | 19.5 x | 10.6 x | 9.34 x | 9.71 x | 7.4 x | 6.42 x |
| EV / FCF | - | - | 323 x | 31 x | 27.7 x | 15.4 x | 24.9 x | 33.2 x |
| FCF Yield | - | - | 0.31% | 3.23% | 3.61% | 6.5% | 4.01% | 3.01% |
| Price to Book | 4.21 x | 6.88 x | 5.86 x | 3.77 x | 2.65 x | 2.38 x | 2.05 x | 1.81 x |
| Nbr of stocks (in thousands) | 402,869 | 402,869 | 402,869 | 402,869 | 406,371 | 406,371 | - | - |
| Reference price 2 | 52.79 | 101.5 | 100.9 | 79.92 | 63.12 | 64.61 | 64.61 | 64.61 |
| Announcement Date | 4/28/20 | 3/29/21 | 3/28/22 | 3/19/23 | 3/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,701 | 9,831 | 11,841 | 15,811 | 11,478 | 13,739 | 16,461 | 17,181 |
| EBITDA 1 | 1,778 | 1,827 | 2,022 | 2,789 | 2,625 | 2,564 | 3,147 | 3,416 |
| EBIT 1 | 1,399 | 1,434 | 1,444 | 2,147 | 1,869 | 1,818 | 2,444 | 2,660 |
| Operating Margin | 16.08% | 14.58% | 12.19% | 13.58% | 16.29% | 13.23% | 14.85% | 15.48% |
| Earnings before Tax (EBT) 1 | 1,398 | 1,420 | 1,440 | 2,135 | 1,866 | 1,813 | 2,424 | 2,677 |
| Net income 1 | 1,170 | 1,210 | 1,222 | 1,794 | 1,565 | 1,529 | 2,020 | 2,237 |
| Net margin | 13.44% | 12.3% | 10.32% | 11.35% | 13.64% | 11.13% | 12.27% | 13.02% |
| EPS 2 | 2.904 | 3.003 | 3.033 | 4.454 | 3.868 | 3.732 | 4.877 | 5.505 |
| Free Cash Flow 1 | - | - | 122.3 | 957.4 | 885.3 | 1,617 | 934 | 660 |
| FCF margin | - | - | 1.03% | 6.06% | 7.71% | 11.77% | 5.67% | 3.84% |
| FCF Conversion (EBITDA) | - | - | 6.05% | 34.33% | 33.73% | 63.06% | 29.68% | 19.32% |
| FCF Conversion (Net income) | - | - | 10.01% | 53.36% | 56.57% | 105.78% | 46.23% | 29.51% |
| Dividend per Share 2 | 0.5000 | 0.5000 | 0.5000 | 1.000 | 0.8800 | 0.8900 | 1.369 | 1.278 |
| Announcement Date | 4/28/20 | 3/29/21 | 3/28/22 | 3/19/23 | 3/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,600 | 5,268 | 4,298 | 3,537 | 2,708 | 4,500 | 2,567 | 2,207 | 3,176 | 4,397 | 3,250 | 2,987 | - | - |
| EBITDA 1 | - | 1,210 | 826.3 | 419.8 | - | - | - | - | - | 700 | 544.1 | 508.5 | - | - |
| EBIT 1 | 236.9 | 1,075 | 715.5 | 176.1 | 180.3 | 889.4 | 446.9 | 283.7 | 500.1 | 597.3 | 441.5 | 405.8 | - | - |
| Operating Margin | 9.11% | 20.41% | 16.65% | 4.98% | 6.66% | 19.76% | 17.41% | 12.85% | 15.75% | 13.58% | 13.58% | 13.58% | - | - |
| Earnings before Tax (EBT) 1 | 232.7 | 1,075 | 718 | 162.1 | 180.5 | 889.3 | 446.7 | 283.7 | 500.1 | 597.3 | 441.5 | 397.6 | - | - |
| Net income 1 | 206.5 | 904.3 | 610.2 | 123.8 | 155.9 | 754.3 | 369.5 | 237 | 429.1 | 597.3 | 441.5 | 55.53 | - | - |
| Net margin | 7.94% | 17.17% | 14.2% | 3.5% | 5.76% | 16.76% | 14.4% | 10.74% | 13.51% | 13.58% | 13.58% | 1.86% | - | - |
| EPS 2 | 0.5077 | 2.245 | 1.515 | 0.3077 | 0.3846 | 1.872 | 0.9169 | 0.5797 | 1.056 | 1.470 | 1.086 | 0.1366 | - | - |
| Dividend per Share 2 | 0.5000 | - | - | - | - | - | - | - | - | 0.2187 | 0.2187 | 0.2187 | 0.2502 | 0.2502 |
| Announcement Date | 3/28/22 | 4/25/22 | 8/28/22 | 10/24/22 | 3/19/23 | 4/24/23 | 8/28/23 | 10/23/23 | 4/22/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 887 | 1,185 | 2,547 | 1,142 | 1,365 | 2,964 | 4,336 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 122 | 957 | 885 | 1,617 | 934 | 660 |
| ROE (net income / shareholders' equity) | 25.5% | 22.2% | 17.6% | 23.2% | 17.3% | 14.2% | 16.2% | 15.7% |
| ROA (Net income/ Total Assets) | 11.6% | 11.8% | 9.48% | 12.9% | - | 9.7% | 10.5% | 11% |
| Assets 1 | 10,063 | 10,267 | 12,893 | 13,948 | - | 15,760 | 19,241 | 20,334 |
| Book Value Per Share 2 | 12.50 | 14.80 | 17.20 | 21.20 | 23.80 | 27.20 | 31.60 | 35.70 |
| Cash Flow per Share 2 | 3.400 | 3.420 | 3.610 | 5.270 | 5.890 | 5.950 | 7.740 | 6.690 |
| Capex 1 | 779 | 1,162 | 1,330 | 1,167 | 1,509 | 515 | 1,231 | 1,135 |
| Capex / Sales | 8.95% | 11.82% | 11.23% | 7.38% | 13.15% | 3.75% | 7.48% | 6.61% |
| Announcement Date | 4/28/20 | 3/29/21 | 3/28/22 | 3/19/23 | 3/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
64.61
CNY
Average target price
77.84
CNY
Spread / Average Target
+20.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.36% | 3.58B | |
| -17.31% | 2.21B | |
| -9.80% | 1.85B | |
| +3.66% | 1.8B | |
| -1.86% | 1.6B | |
| +2.91% | 1.1B | |
| -22.39% | 1.02B | |
| -4.02% | 951M | |
| +2.36% | 846M | |
| -19.44% | 772M |
- Stock Market
- Equities
- 600486 Stock
- Financials Jiangsu Yangnong Chemical Co., Ltd.
